Elsa Hebbo

ORCID: 0000-0002-3378-8821
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Cardiac Valve Diseases and Treatments
  • Cardiac and Coronary Surgery Techniques
  • Cardiac Imaging and Diagnostics
  • Transplantation: Methods and Outcomes
  • Infective Endocarditis Diagnosis and Management
  • Atrial Fibrillation Management and Outcomes
  • Acute Myocardial Infarction Research
  • Mechanical Circulatory Support Devices
  • Viral Infections and Immunology Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Issues in Pregnancy
  • Pulmonary Hypertension Research and Treatments
  • Radiomics and Machine Learning in Medical Imaging
  • Alzheimer's disease research and treatments
  • Advanced X-ray and CT Imaging
  • COVID-19 and healthcare impacts
  • Cardiac Arrhythmias and Treatments
  • COVID-19 and Mental Health
  • Gut microbiota and health
  • Tryptophan and brain disorders
  • Cardiac electrophysiology and arrhythmias
  • Cardiac, Anesthesia and Surgical Outcomes
  • Palliative Care and End-of-Life Issues

Emory University
2024-2025

Emory Clinic
2024-2025

Emory University Hospital
2024

American University of Beirut Medical Center
2024

American University of Beirut
2022-2023

Abstract: Evidence that the gut microbiota plays a key role in pathogenesis of Alzheimer’s disease is already un-ravelling. The microbiota-gut-brain axis bidirectional communication system not fully understood but includes neural, immune, endocrine, and metabolic pathways. progression supported by mechanisms related to imbalance development amyloid plaques brain, which are at origin Alzheimer's disease. Alterations composition microbiome led dysregulation pathways governing this system. This...

10.2174/1567205020666221227090125 article EN Current Alzheimer Research 2022-10-01

We describe a case of valve thrombosis and subsequent thromboembolic event within only 10 days transcatheter aortic implantation (TAVI). Postprocedural anticoagulants are not standard care medications post-TAVI in patients without atrial fibrillation. Valve is an indication to initiate anticoagulation resolve prevent further thrombus.

10.3389/fcvm.2023.1164668 article EN cc-by Frontiers in Cardiovascular Medicine 2023-06-20

Background:The objective of this study was to explore the impact COVID-19 on lived experiences patients with cancer in Lebanon.Methods: We adopted a descriptive phenomenological approach.We included adults who had been diagnosed before pandemic and undergoing treatment at American University Beirut Medical Centre.We conducted virtual, semi-structured in-depth interviews either video or audio recordings.Two team members coded transcripts independently identified common themes patterns....

10.3332/ecancer.2023.1598 article EN cc-by ecancermedicalscience 2023-09-04

We use vernakalant, an intravenous anti-arrhythmic, to cardiovert paroxysmal atrial fibrillation (AF) into sinus rhythm. It is a relatively atrium-selective, early-activating potassium and frequency-dependent sodium channel blocker with half-life of 2 3 hours. Due concerns regarding its safety profile, it not Food Drug Administration (FDA)-approved.

10.7759/cureus.58616 article EN Cureus 2024-04-19

Patients who have undergone orthotropic heart transplantations (OHT) may develop cardiac allograft vasculopathy (CAV), associated with increased mortality. CAV is frequently treated percutaneous coronary intervention (PCI) when focal lesions are present. Drug eluting stents (DES) allowed treatment of small vessels, but little known about the rate restenosis in this patient population. This a retrospective observational study 71 vessels 42 OHT patients DES diameter 2.5 mm or less during PCI...

10.1016/j.jscai.2024.101737 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

Both percutaneous coronary interventions (PCI) and robotic-assisted artery bypass surgery (CAB) can provide left anterior descending (LAD) chronic total occlusion (CTO) revascularization. We compare long term clinical outcomes between the two strategies. retrospectively analyzed a of 273 CTO patients who underwent either PCI (129) or CAB (144) at single institution. Long-term follow up was available for 96 125 patients. Cumulative survival analyses, free myocardial infarction (MI) repeat...

10.1016/j.jscai.2024.101425 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

BackgroundBoth percutaneous coronary interventions (PCIs) and robotic-assisted artery bypass (CAB) offer viable options for left anterior descending (LAD) chronic total occlusion (CTO) revascularization. Our study aims to compare long-term clinical outcomes associated with these 2 strategies.MethodsIn this retrospective study, we analyzed data from 273 patients diagnosed LAD CTO who underwent either PCI (n = 129) or CAB 144) at a single institution. Long-term follow-up was available 96 125...

10.1016/j.jscai.2024.102278 article EN cc-by Journal of the Society for Cardiovascular Angiography & Interventions 2024-10-01

Background: The current guideline-recommended intervention for left main (LM) disease is coronary artery bypass grafting (CABG). Hybrid revascularization (HCR) combines robotic and percutaneous (PCI) offers a less invasive approach patients with LM multivessel disease. We aim to compare clinical outcomes at 30 days, 6 months 1 year between HCR CABG in Methods: retrospectively screened 761 who underwent 2019 2023 single institution. A total of 118 either (n=59) or were included after...

10.1161/circ.150.suppl_1.4137855 article EN Circulation 2024-11-12
Coming Soon ...